Torrent Pharmaceuticals 配当と自社株買い
配当金 基準チェック /46
Torrent Pharmaceuticals配当を支払う会社であり、現在の利回りは0.88%で、収益によって十分にカバーされています。
主要情報
0.9%
配当利回り
n/a
バイバック利回り
| 総株主利回り | n/a |
| 将来の配当利回り | 1.1% |
| 配当成長 | -3.3% |
| 次回配当支払日 | n/a |
| 配当落ち日 | n/a |
| 一株当たり配当金 | ₹28.000 |
| 配当性向 | 55% |
最近の配当と自社株買いの更新
Recent updates
Earnings Miss: Torrent Pharmaceuticals Limited Missed EPS By 7.7% And Analysts Are Revising Their Forecasts
Oct 29
Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) Popularity With Investors Is Under Threat From Overpricing
Oct 24Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Just Reported And Analysts Have Been Lifting Their Price Targets
Jul 26Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) P/E Is On The Mark
Apr 16Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Have A Healthy Balance Sheet?
Mar 03Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹22.00
Feb 05Investors Interested In Torrent Pharmaceuticals Limited's (NSE:TORNTPHARM) Earnings
Jan 07Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Rather Sparingly
Nov 14Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Jun 01Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Mar 01Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Jul 25Torrent Pharmaceuticals' (NSE:TORNTPHARM) Soft Earnings Don't Show The Whole Picture
Jun 02Estimating The Fair Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
May 25A Look At The Intrinsic Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
Feb 18Torrent Pharmaceuticals (NSE:TORNTPHARM) Is Increasing Its Dividend To ₹25.00
Jan 27Here's Why Torrent Pharmaceuticals (NSE:TORNTPHARM) Can Manage Its Debt Responsibly
Jan 04Here's Why I Think Torrent Pharmaceuticals (NSE:TORNTPHARM) Is An Interesting Stock
Dec 14A Look At The Fair Value Of Torrent Pharmaceuticals Limited (NSE:TORNTPHARM)
Nov 07Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Sep 30Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Deserve A Spot On Your Watchlist?
Sep 01Torrent Pharmaceuticals (NSE:TORNTPHARM) Seems To Use Debt Quite Sensibly
Jul 02I Ran A Stock Scan For Earnings Growth And Torrent Pharmaceuticals (NSE:TORNTPHARM) Passed With Ease
Jun 01Torrent Pharmaceuticals Limited (NSE:TORNTPHARM) Shares Could Be 30% Above Their Intrinsic Value Estimate
May 14Does Torrent Pharmaceuticals (NSE:TORNTPHARM) Have A Healthy Balance Sheet?
Mar 23決済の安定と成長
配当データの取得
安定した配当: TORNTPHARMの配当金支払いは、過去10年間 変動性 が高かった。
増加する配当: TORNTPHARMの配当金は過去10年間にわたって増加しています。
配当利回り対市場
| Torrent Pharmaceuticals 配当利回り対市場 |
|---|
| セグメント | 配当利回り |
|---|---|
| 会社 (TORNTPHARM) | 0.9% |
| 市場下位25% (IN) | 0.3% |
| 市場トップ25% (IN) | 1.2% |
| 業界平均 (Pharmaceuticals) | 0.7% |
| アナリスト予想 (TORNTPHARM) (最長3年) | 1.1% |
注目すべき配当: TORNTPHARMの配当金 ( 0.88% ) はIndian市場の配当金支払者の下位 25% ( 0.25% ) よりも高くなっています。
高配当: TORNTPHARMの配当金 ( 0.88% ) はIndian市場の配当金支払者の上位 25% ( 1.15% ) と比較すると低いです。
株主への利益配当
収益カバレッジ: TORNTPHARMの配当金は、合理的な 配当性向 ( 54.6% ) により、利益によって賄われています。
株主配当金
キャッシュフローカバレッジ: TORNTPHARMの 現金配当性向 ( 32.4% ) は比較的低く、配当金の支払いはキャッシュフローによって十分にカバーされています。